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1) Method summary (1-3 sentences)  
Flavonoids at physiological concentrations emit only low levels of fluorescence which 
are not visible by microscopy in situ. A dye that has been used to enhance 
fluorescence of polyphenolic pigments in plant tissues was found to be effective in 
studies of flavonoid therapeutics in a model eukaryotic microbe, Dictyostelium 
discoideum. Use of a simple buffer and fixative on treated cells allows flavonoid 
transport and localisation to be monitored in vivo, using epifluorescence and confocal 
microscopy. 
 
Abstract 
Naturstoff reagent A (diphenylboric acid 2-aminoethyl ester, DPBA) has been used 
historically in plant science to observe polyphenolic pigments, such as flavonoids, 
whose fluorescence requires enhancement to be visible by microscopy. Flavonoids 
are common dietary constituents and are the focus of considerable attention because 
of their potential as novel therapies for numerous diseases. The molecular basis of 
therapeutic activity is only gradually being established, and one strand of such 
research is making use of the social amoeba Dictyostelium discoideum. We extended 
the application of DPBA to flavonoid imaging in these preclinical studies and report the 
first method for use of DPBA in this eukaryotic model microbe, and its applicability 
alongside subcellular markers. This in vivo fluorescence imaging provided a useful 
adjunct to parallel chemical and genetic studies. 
 
2) Introduction 
Flavonoids constitute a large family of polyphenolic compounds that have been widely 
suggested to endow health benefits, ranging from anticancer, anti-inflammatory, 
antiviral and anti-allergic activity, through to treatment of diabetes and Alzheimer’s 
disease [1-3]. Flavonoids  are not be synthesised by animals or their gut microbiota 
but are abundant in our diet because they are secondary metabolites of plants. They 
act as pigments and bitter flavours, attracting pollinators or protecting against UV and 
herbivory, but can also modulate plant development and root–microbial symbioses [4-
6]. The anti-oxidant activity shared by many of these compounds has been 
hypothesised to underlie purported therapeutic benefits, and numerous studies do 
demonstrate links between health outcomes and flavonoids. The literature, however, 
does not describe well the specific transport, biological activity, and chemical fate upon 
ingestion, of individual compounds. These are subject to compound size, 
configuration, lipophilicity and solubility, and flavonoids possess diverse chemical 
subgroups and modifications, the latter including hydroxylation, glycosylation, 
methylation and polymerisation [7] (Figure 1). For example, such compound specificity 
was described previously for the activities of plant polyphenols: only a subset of 
flavonoids affect the transport of the plant hormone auxin, and thus plant development 
[6,8,9]. The biomedical literature has recently begun to follow suit with reports of 
particular polyphenolic secondary metabolites acting via individual protein targets and 
reaching distinct subcellular compartments [10,11]. There is also limited evidence for 
some pathways of flavonoid metabolism in humans, namely glucuronidation, o-
methylation, and addition of glutathione, depending on where the compounds are 
absorbed [12]. Of note therapeutically, aglycones have been reported to be readily 
absorbed whereas glycosides must be transformed into the aglycone form [13]. 
Flavonoids, however, are most commonly found as glycosides in plants [15], so there 
are questions over transport of compounds even when robustly shown to have useful 
therapeutic activity.  
Examples of evidence for activity of kaempferol (3,4′,5,7-tetrahydroxyflavone) 
were the inhibition of growth of lung cancer lines [16] and induction of cancer-cell 
apoptosis [15]. Naringenin (4',5,7-trihydroxyflavanone) reduced cyst formation in both 
animal and in vitro studies of polycystic kidney disease (PKD): its action via the PKD2 
protein, indeed, was first demonstrated in the model microbe Dictyostelium [11]. 
Furthermore, naringenin, kaempferol and quercetin (3,3',4',5,7-pentahydroxyflavone) 
have been reported to inhibit phosphoinositide 3-kinase, nuclear factor B pathway and 
kinases involved in pro-apoptic signalling in cancer cells [17,18].  
These polyphenolic compounds can be quantified in tissue extracts by UV–
visible spectroscopy, high-performance liquid chromatography, mass spectrometry 
methods and nuclear magnetic resonance [19,20]. Flavonoids exhibit only low levels 
of fluorescence, however, and cannot be viewed at physiologically relevant 
concentrations in vivo. A method was therefore developed several decades ago for 
visualising them in plant tissues using the fluorescent probe Naturstoff reagent A 
(diphenylboric acid 2-aminoethyl ester; DPBA). The specificity of the probe for 
flavonoids was demonstrated in plants including Arabidopsis thaliana [21-23] and it 
has, infrequently, been applied in human in vitro cell cultures. For example, apigenin 
(4′,5,7-trihydroxyflavone) was visualised in mitochondria of monocytic leukaemia 
(THP-1) cells [24]; quercetin and kaempferol in the nucleus of umbilical endothelial 
cells; and quercetin at the cell membrane in epithelial colorectal adenocarcinoma cells 
[7,25,26].  
The mechanism by which the fluorescent probe binds to polyphenolics is not 
well-described: it was proposed to form a spontaneous complex with flavonoids, 
resulting in an increase in fluorescence [27], but this is not the case for all members 
of the family. The use of DPBA by was recorded by the German researcher Neu in 
1961 [28], who described its synthesis by modifying Schiff’s reagent with a nitrogen 
donor and two aromatic aldehydes. Neu suggested various complex formations with 
a range of pyridine compounds, and areas of complexation, and hypothesised that a 
minimum of one hydroxyl group was required for conjugation [28]. Two decades later, 
Brasseur and Angenot [29] showed that a minimum of two hydroxyl groups (Figure 1) 
were required for the flavonoid–DPBA conjugate to form. They also recorded the 
colour of fluorescence emission from a range of polyphenolic compounds under UV 
excitation [29]. In 2011, Matteini et al. [30] described various possibilities for complex 
formation between DPBA and rutin [3,3',4',5,7-pentahydroxyflavone 3-(O-
rhamnosylglucoside)] and hypothesised that DPBA could conjugate at two sites of the 
flavonoid backbone, either between the 5-hydroxy-4-keto sites of the A-C ring, or the 
3-4-o-diphenolic site of the B ring (Figure 1).  
We explored further the utility of DPBA, with a range of plant or microbial 
metabolites whose biological activity was under investigation in a biomedical model 
microbe. The social amoeba Dictyostelium discoideum is a eukaryotic model organism 
whose life cycle includes phagocytosis of bacterial prey, before signalling and 
aggregation of motile cells leads to formation of a multicellular ‘slug’ with differentiated 
cell types [31]. It is an ideal biomedical model for various aspect of cell biology [32,33], 
and D. discoideum is also no stranger to flavonoid research. For example, a 
Dictyostelium mutant library was employed in the studies of naringenin, which 
identified the PKD2 cation-channel target [11] and of curcumin [34], and the amoeba 
was also employed to explore the chemotactic effect of bitter tastants [35]. Given the 
evidence for differential uptake of flavonoids, including long-distance transport [36], 
for involvement of specific transporter proteins [9,37,38] and the possibility of efflux 
(unpublished data), there is a need to observe localisation of flavonoid-treatment and 
target in vivo. We found that differential uptake and targeting of therapeutically relevant 
flavonoids in the model amoeba could be visualised, and flavonoid localisation could 
be imaged along with other cell markers, using the DPBA probe.  
 
Materials and methods 
Dictyostelium discoideum cells were grown axenically in HL5 medium (Formedium, 
Hunstanton, UK) at 22°C to a density of 106 cells/ml. Cells were washed twice by 
pelleting (500 g, 4 min) and resuspended in potassium dibasic (KK2) buffer. Cells were 
then pelleted and resuspended in LoFlo broth (Formedium) at 5 x 105 cells/ml and re-
incubated (22°C 180 rpm) for 24 h. After incubation, cells were transferred to a Petri 
dish containing sterile coverslips: 15 ml of cells at a final density of 5 x 106 cells/ml in 
LoFlo were allowed to settle onto the coverslips for 30 min. 
 
For treatment with flavonoids, the appropriate molarity of the compound of interest 
was prepared using a maximum of 0.1% dimethyl sulfoxide (DMSO) in deionised water 
(no flavonoid, versus final concentrations of DMSO, were 25 µM, 0.025%; 50 µM, 
0.05%; 100 µM, 0.1%). The selected treatment was added to the 15 ml LoFlo broth in 
a Petri dish, into which the coverslips and attached cells were transferred. Incubation 
for 30 min (or 0, 20, 40 or 60 min for time-course assay) at 22 °C was followed by 
rinsing, by dipping coverslips in 0.1M potassium phosphate buffer (PPB) pH6.8, then 
drying excess liquid from the glass with filter paper (Whatmann, Maidstone, UK), by 
capillary action.  
 
For imaging, 0.1% w/v DPBA solution in ethanol was pipetted onto treated, adhered 
cells on coverslips, and allowed to stain for 5 min. DPBA was rinsed from coverslips 
by dipping into 0.1M PPB once more, and blotting dry with filter discs again. Where 
required, cells were treated with organelle stains [DAPI (1 µg/ml; Abcam, Cambridge, 
UK), MitoTracker (100 nM; Fisher) or FM4-64 (5 µg /ml; Fisher)] according to the 
manufacturer’s protocol, before (MitoTracker) or after (DAPI, FM4-64) treatment and 
DPBA staining. 
 
Treated and stained cells on coverslips were then fixed with 2% v/v paraformaldehyde 
[in phosphate-buffered saline pH 7 (PBS)] for 20 min, and the excess rinsed off using 
PBS before a further filter-paper blot to dry. One drop of 1% v/v n-propyl gallate 
mounting medium (in glycerol:PBS 60:40% v/v; approx. 5–10 µl) was added to 
microscope slides and coverslips mounted to slides. Coverslips were sealed to slides 
using nail polish, and samples viewed by epifluorescence or confocal microscopy 
(LSM 880, Zeiss, Cambridge, UK) and images processed using ZEN software (Zeiss). 
Fixed samples were stored at –20 °C. 
 
All experiments were performed a minimum of three times, with a minimum of three 
biological replicates per experiments.  
 
Results and discussion 
DPBA-enhanced epifluorescence microscopy 
To determine whether DPBA-enhanced fluorescence emission could be successfully 
employed in Dictyostelium, cells were first viewed with and without DPBA treatment, 
via epifluorescence using the UV2A cube (Nikon) that limits excitation wavelength to 
330–380 nm and emission to ≥420 nm, to check for autofluorescence. Cells grown 
axenically had been transferred to low-fluorescence medium and, following incubation, 
images were acquired using epifluorescence microscopy. Since there was no 
background cell autofluorescence (Figure 1A) in untreated wild type (AX2) cells nor 
cells treated with 0.1% (w/v) DPBA (Figure 1B), our protocol for visualising plant native 
flavonoids (Thompson et al., 2010) was modified for use with this model microbe. 
Three test flavonoids were chosen according to well documented activity (as 
summarised above) in tissue culture, or from study using Dictyostelium, and 
concentrations for treatment were guided by those reports and parallel studies here of 
viability and life cycle progression in Dictyostelium (Suppl. Fig. 1). Cells were therefore 
treated with 50 µM kaempferol, naringenin and quercetin for 30 min. With addition of 
DPBA to prepared samples, epifluorescence could be used to view cells adhered to 
microscope slides that had undergone a time-course of treatment up to 60 min 
incubation with test flavonoid: it was possible to visualise kaempferol and quercetin 
after treatments of approx. 20 min (Figure 1C,D), and low fluorescence from 
naringenin was observed after approx. 40 min. Without the use of the flavonoid 
fluorescence enhancer, no signal was observed from D. discoideum cells treated with 
any flavonoid (Suppl. Fig. 2) and no fluorescence was detected in solvent 
(DMSO)/DPBA controls (Suppl. Fig. 2). The fluorescent probe therefore did permit in 
vivo visualisation of flavonoid fluorescence for three flavonoids of therapeutic interest 
in this model microbe. 
Dosage assay  
Biological and transcriptional responses, such as cell rounding and toxin transporter 
upregulation were observed when Dictyostelium was treated with kaempferol, 
naringenin or quercetin at 10–50 µM, viability only declining for one compound, namely 
kaempferol with treatment of 100 µM (Suppl. Fig. 1). To discern concentration-
dependent effects by imaging, cells were therefore incubated (20 min) with 0–100 µM 
treatment and 0.1% DPBA: the resultant fluorescence signal in amoebae was 
enhanced in line with increasing concentration. As before, kaempferol (Figure 2) and 
quercetin were most easily detectable, at concentrations ≥25 µM, whereas naringenin 
fluorescence was not observed below 50 µM and was most visible at 100 µM (Suppl. 
Fig. 3).  
Time course assay 
The physiologically relevant 50 µM concentration was then used in a time-course 
experiment. Differential accumulation of flavonoids (Figures 1, 2) again occurred in 
Dictyostelium as seen in other organisms and cell types [7,36], since quercetin 
fluorescence was visible after 10-min incubation, whereas for kaempferol visualisation 
a treatment of at least 20 min was required. Naringenin required the longest incubation 
for detectable fluorescence, becoming most easily visible after 60 min treatment 
(Suppl. Fig. 4). 
 
 
Confocal microscopy of co-localisation dyes in conjunction with fluorescence 
enhancement 
An increase in fluorescence could be the result of flavonoids bound to the surface of 
Dictyostelium cells rather than differential uptake. Therefore more sensitive, confocal, 
microscopy was employed and cell extracts were subjected to LCMS quantification to 
monitor flavonoid levels within cells. As noted above, dependent on cell type tested, 
flavonoids have been reported to localise to the nucleus or mitochondria, or the plant-
cell vacuole. To test if colocalisation dyes could be used in conjunction with DPBA to 
allow subcellular location of flavonoids to be identified, Dictyostelium cells were treated 
with 50 µM naringenin, quercetin or kaempferol, viewed using 488 nm excitation and 
520 nm emission, along with the DAPI nuclear marker (excitation, 405 nm, emission 
461 nm), FM4-64 (excitation, 561 nm, emission 737 nm) for plasma or vacuole 
membranes, or MitoTracker Red (excitation, 561 nm, emission 599 nm) to stain the 
mitochondria [39-41].  
Using the confocal microscope improved image quality when viewing DPBA-
enhanced fluorescence and it was possible, as hoped, to visualise subcellular 
fluorescence from standard organelle markers as well as from the DPBA–flavonoid. A 
previous report on subcellular localisation stated that a range of flavonols might reach 
the nuclei of cancer cells and induce DNA cleavage [42] and that quercetin reduced 
oxidative DNA damage and quenched free radicals in isolated DNA in vitro [43]. This 
co-treatment protocol, however, revealed that points of brightest fluorescence from the 
three test flavonoids did not occur at the nucleus, the fluorescence from kaempferol 
(Figure 3), naringenin and quercetin (Suppl. Fig. 5) being largely independent of the 
DAPI emission in merged images. Here, as previously reported, MitoTracker Red (the 
import of which is dependent upon the organelle’s membrane potential) stained 
Dictyostelium variably, also accumulating in circular “submitochondrial bodies” in the 
cytoplasm [44,45]. MitoTracker–flavonoid colocalisation was visible, however (Figure 
3; see also Suppl. Fig. 5), in agreement with the purported anti-oxidant properties of 
flavonoids: both quercetin and kaempferol were previously suggested to be cytotoxic 
to cancer cell lines by stimulating the mitochondria to overproduce ATP [46-48]. FM4-
64 stained the plasma membrane and was internalised over time so that at 15 min it 
could be seen within Dictyostelium cells, at the contractile vacuole. The merged 
kaempferol and FM4-64 staining overlapped (Figure 3), in agreement with high 
kaempferol levels (Suppl. Fig 6) confirmed by LCMS in cell extracts (Suppl. Table 1). 
 Parallel LCMS detection of flavonoids (Suppl. Table 1) showed naringenin was 
present in cell washes not cell extracts, and suggested significant quantities were not 
actively imported into Dictyostelium cells and that flavonoid fluorescence was imaged 
at the cell exterior. This was in agreement with the low fluorescence emission from 
naringenin seen in the dosage study (Figure 2), and the peripheral location of its 
reported target protein, PKD2, at the plasma membrane of both MDCK [49] and D. 
discoideum cells [50]. 
Use of fluorescence enhancement with specific flavonoid subtypes 
Whereas three flavonoids were initially successfully imaged in Dictyostelium, in vitro 
assays of human cells detected DPBA-enhanced fluorescence from apigenin (in 
macrophages) [41] and hesperetin (3′,5,7-trihydroxy-4′-methoxyflavanone; in Caco2 
cells) [7]. Whereas our LCMS measurements showed that Dictyostelium cells were 
able to import the flavones apigenin and, luteolin (3′,4′,5,7-tetrahydroxyflavone) and 
the flavanone hesperetin (the latter being slow to accumulate, however), none of these 
were visible using confocal or epifluorescence microscopy of flavonoid–DPBA-treated 
Dictyostelium cells. The mechanisms for flavonoid influx into human cells have not 
been fully elucidated and observations have been reported to differ based on 
flavonoid, cell type and sample preparation, and this might equally apply to amoebae. 
There may be more passive diffusion of the less-polar aglycones [41] than of the more 
commonly found glycoside forms [51]. The extent of this is not known versus active 
transport and efflux, although our chemical inhibition studies suggest that flavonoid 
efflux is an active process (manuscript in preparation). The differences in flavonoid 
influx previously reported are in agreement with the treatment length and 
concentration here both being seen to influence flavonoid detection via DPBA-
enhanced imaging. In this study, quercetin was rapidly transported by Dictyostelium 
cells, being visible at 25 µM after 10 min, and kaempferol was also detectable after 25 
µM treatment for 20 min incubation (Figure 2). Naringenin was only minimally imported 
or not at all, requiring higher concentrations of 50–100 µM and requiring longer 
incubation for fluorescence to become visible (Figure 2, Suppl. Fig. 2,3). Therapeutic 
use of naringenin is still possible, however, since it can exert a biological effect via the 
PKD2 target that is located at the cell boundary [49].  
 
Chemical basis for DPBA conjugation 
Searches of over half a century of literature yielded little detail of the mechanisms of 
DPBA–polyphenolic conjugation, but it was reported that the chemical structure of a 
compound determined both whether DPBA-enhancement of fluorescence emission 
occurs and its wavelength [30]. A hydroxyl group at the C3 position of the flavonoid 
skeleton (Figure 1) was suggested to be essential for fluorescence [39]. The flavanone 
naringenin is interesting in this respect, as it demonstrated weak DPBA-enhanced 
fluorescence in Dictyostelium, despite missing the hydroxyl group in the 3′ position of 
the C-ring (Figure 1), in contrast with hesperitin which was not visible. Another report 
suggested a minimum of two hydroxyl groups were required [29] but, again, the 
chemical structure of naringenin fits this criterion for conjugation with DPBA. The low 
fluorescence of this compound in vivo may correlate with low concentrations bound to 
the cell surface, along with little import of naringenin. 
Such differential accumulation of flavonoids is in agreement with other 
research, and underlines both the need for further studies of transport and 
bioavailability and the usefulness of in vivo imaging. Mouse liver hepatoma cells 
(HEPA-1c1c7), human umbilical vein endothelial cells (HUVEC), mouse 
neuroblastoma cells (Neuro 2A) and human epithelial colorectal Caco-2 cells [24-26] 
all showed different levels of accumulation of specific flavonoids, clearly pertinent to 
medical application of flavonoids as therapeutic compounds. The in vivo imaging 
method developed here is superior to LCMS and HPLC in not requiring cell 
fractionation nor solvent extraction of cellular components and compounds, and takes 
much less time. The evolutionary conservation of flavonoid targets in Dictyostelium 
and human cells and its popularity as a model organism means that this DPBA-
enhanced in vivo imaging can be a useful adjunct to the necessary research on the 
mechanism of entry, selectivity and exit of flavonoids. In summary, DPBA-enhanced 
imaging can be used to reveal an association of flavonoids with Dictyostelium cells 
which can be viewed very simply with epifluorescence microscopy. For more detailed 
localisation and dynamics of uptake, DPBA-enhanced confocal microscopy, and 
analytical chemistry for quantification, should be carried out. Identifying a compound’s 
location in this model organism will help inform work on cellular targets, and ultimately 
progress the development of flavonoids from widely reported nutraceuticals to licensed 
therapies.  
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 Protocol 
 
Reagents 
HL-5 Medium (ForMedium) 
Lo-Flo Medium (ForMedium) 
Microscope slides (VWR) 
25mm coverslips (VWR) 
Filter discs (Fisher Scientific) 
Dimethyl sulphoxide (Sigma) 
1x KK2 buffer 
Flavonoids (Fisher Scientific; Sigma) 
DPBA (Acros Organics) 
0.1 M potassium phosphate buffer (PPB) pH 6.8  
Ethanol (100%) 
10x PBS pH 7.4 (25.6 g Na2HPO4·7H2O, 80 g NaCl, 2 g KCl, 2 g KH2PO4) 
1x phosphate buffered saline (PBS) pH 7.4  
5x PBS pH 7.4 
2% v/v paraformaldehyde (Sigma)  
1% v/v N-propyl gallate mounting medium (Sigma)  
Nikon Eclipse 90i overhead microscope 
Confocal microscope LSM880 (Zeiss) 
MitoTracker (Fisher) 
DAPI (Abcam) 
FM4-64 (Fisher) 
 
Preparation of cells 
1. Grow cells axenically in 30 ml HL-5 medium at 22 °C 180 rpm for 2-3 days until 
a density of 107 cells/ml. 
2. Retrieve 30 ml culture and proceed with KK2 wash to remove HL-5 medium:  
a. Transfer culture to 50 ml falcon tube and pellet at 500g 4 min. 
b. Discard supernatant, top up to 15 ml with 1x KK2 buffer, resuspend pellet, spin 
at 500g 4 min. 
c. Discard supernatant, top up to 15 ml with 1x KK2 buffer, resuspend pellet, spin 
at 500g 4 min. 
3. After the second KK2 wash, resuspend the cell pellet in 20 ml 1x KK2 and count 
cells. Once counted, resuspend cells to a final cell density of 5x105 cells/ml in 30 ml 
Lo Flo medium in a sterile 250 ml conical flask.  
4. Return cells to incubator for 24 h at 22 °C 180 rpm. 
5. After 24 h, transfer cells to a petri dish containing sterile cover slips and 15 ml 
of Lo Flo, to a final density of 5x106 cells/ml. Allow cells to attach to coverslips for 30 
min. 
 
 
Flavonoid treatment 
1. Retrieve Petri dish containing cells attached to coverslips in LoFlo medium. 
2. Proceed with your flavonoid treatment. Coverslips with attached cells were 
transferred to a fresh petri dish containing 15 ml Lo Flo medium + 50 µM of flavonoid. 
Petri dishes were returned to the incubator for 30 m at 22 °C. 
3. After the 30 m incubation, retrieve coverslips and remove from petri dish. Rinse 
coverslips with 0.1M PPB pH 6.8 and blot dry with filter discs by capillary. 
a. *Hint: to rinse coverslips, dip slips into a beaker containing buffer. 
Excitation of tissues stained with 0.1% (w/v) DPBA in 0.1 M potassium phosphate 
buffer pH 6.8, 1% NaCl (w/v) (Hutzler et al., 1998) [53] 
 
Staining with DPBA 
1. Apply 0.1% DPBA staining solution onto coverslip, allow to stain for 5 m. 
2. Rinse off DPBA stain from coverslips with 0.1M PPB pH 6.8 and blot dry with 
filter discs by capillary. 
a. *Hint: to rinse coverslips, dip slips into a beaker containing buffer. 
3. Fix coverslips with 2 % PFA for 20 m. Rinse off excess PFA solution using 1X 
PBS blot dry with filter discs by capillary. 
a. *Hint: to rinse coverslips, dip slips into a beaker containing buffer. 
4. To a clean microscope slide, place 1 drop of 1% n-propyl gallate mounting 
medium (approx. 5 – 10 µL) and mount coverslip to the slide. Seal coverslip to slide.  
5. Image slide or store -20 °C until required. 
 
Use of co-localisation markers 
1.Follow supplier’s guidelines for use of cell markers for live or fixed sample imaging. 
 
Recipes 
 
1X KK2 buffer (Eichinger and Rivero, 2006) [52] 
1. 10X solution: Dissolve 22 g KH2PO4 (monobasic) and 7 g K2HPO4 (dibasic) in 
1 L deionized water, autoclave. 
2. Dilute 1:10 with deionized water for 1X concentration. 
0.1M POTASSIUM PHOSPHATE BUFFER (PPB) pH 6.8 
1. Combine 49.7 ml of 1M K2HPO4 and 50.3 ml of 1M KH2PO4 to achieve pH 6.8 
at room temperature. 
2. Make up to 1 L with deionised water. 
1X PBS 
1. 10X solution: to 800 ml of deionised water add 80 g NaCl, 2 g KCl, 14.4 g 
Na2HPO4 and 2.4 g KH2PO4. Adjust pH to 7.4, top up to 1 L. Autoclave. 
2. Dilute 1:2 for 5X, and 1:10 for 1X concentration. 
0.1% DPBA STAIN 
1. Dissolve 125 mg in 10 ml of 100 % ethanol to create 2.5 % stock 
2. Dilute 2.5 % stock down to 0.1 % working solution using PPB pH 6.8 
0.1% N-PROPYL GALLATE MOUNTING MEDIUM 
1. Add 4 ml glycerol to 6 ml 1X PBS. 
2. Dissolve 0.1 g n-propyl gallate in 10 ml solution prepared in step 1. 
a. *Hint: microwave for 5 s if experiencing difficulty with dissolving. 
3. Aliquot 1 ml and store in the dark at 4 °C.   
2% PARAFORMALDEHYDE 
1. Add 45ml 5X PBS to a beaker on hot stir plate at 50 °C 
2. Add 2 g of paraformaldehyde to heated PBS. 
3. Slowly, add 5M NaOH to dissolve PFA. 
4. Cool solution on ice. 
5. Top up to 80 ml with 5X PBS, adjust pH to 7.4, top up to 100 ml. 
6. Aliquot 10 ml and store -20 °C. 
  
Executive summary 
DPBA-enhanced epifluorescence microscopy 
 Addition of Naturstoff reagent A (DPBA) to Dictyostelium cells treated with 
flavonoids allows visualisation of flavonoid fluorescence in vivo by 
epifluorescence  
 There is no autofluorescence from Dictyostelium cells grown in LoFlo medium, 
or treated with solvent or staining buffers 
Visualisation of flavonoid uptake: dosage and time-course  
 Flavonoid fluorescence can be enhanced so that treatment at biomedically 
relevant dosages can be visualised in vivo  
 DPBA imaging is sensitive to flavonoid treatment concentration and differences 
in compound-specific uptake by Dictyostelium cells 
Confocal microscopy of co-localisation dyes in conjunction with fluorescence 
enhancement 
 DPBA-enhanced fluorescence imaging by confocal microscopy is compatible 
with use of localisation markers (for nucleus, mitochondrion, plasma membrane 
and vacuole) in Dictyostelium cells 
 Co-staining with organelle markers and DPBA allows imaging of subcellular 
destination of specific flavonoids 
Use of fluorescence enhancement with specific flavonoid subtypes: chemical basis for 
DPBA conjugation 
 Fluorescence enhancement is dependent on structural or environmental 
factors: DPBA variably enhanced imaging of flavanones, flavonols and 
flavanone. Necessary structural components and conditions for DPBA 
conjugation in vivo require further elucidation. 
 
